Chen, P M <br/><br/>
Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation.  [electronic resource] 

 -  Transplantation  Jun 1999 
 - 1425-33 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-199906150-00006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Alanine Transaminase--blood<br/>Analysis of Variance<br/>Antibodies, Viral--blood<br/>Bone Marrow Transplantation--adverse effects<br/>Carrier State--immunology<br/>Cause of Death<br/>Child<br/>Female<br/>Hepacivirus--immunology<br/>Hepatitis--etiology<br/>Hepatitis Antibodies--blood<br/>Hepatitis B--immunology<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--immunology<br/>Humans<br/>Liver Function Tests<br/>Male<br/>Survival Analysis<br/>Transplantation, Autologous--adverse effects<br/>Transplantation, Homologous--mortality